[CYCC] QoQ Quarter Result on 30-Sep-2015 [#Q3]

Stock
[CYCC] Cyclacel Pharmaceuticals, Inc.
Announcement Date
12-Nov-2015
Financial Year
2015
Quarter
30-Sep-2015 [#Q3]
Profit Trend
QoQ- 19.06%
YoY- 44.79%
Quarter Report
CYCC's Result
CYCC's Financial Summary
View:
Show?
Quarter Result
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
Revenue 222 139 424 715 296 512 247 -6.87%
PBT -3,591 -3,534 -3,872 -3,187 -3,752 -5,675 -5,907 -28.25%
Tax -626 -493 -498 -478 -405 -763 -1,108 -31.68%
NP -2,965 -3,041 -3,374 -2,709 -3,347 -4,912 -4,799 -27.48%
Tax Rate - - - - - - - -
Total Cost 3,187 3,180 3,798 3,424 3,643 5,424 5,046 -26.40%
Ratio Analysis
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
NP Margin -1,335.59 -2,187.77 -795.75 -378.88 -1,130.74 -959.38 -1,942.91 -22.12%
Per Share
30/06/16 31/03/16 31/12/15 30/09/15 30/06/15 31/03/15 31/12/14 CAGR
EPS -19.77 -20.51 -23.15 -18.75 -23.36 -45.23 -50.11 -46.23%
EPS Diluted -19.77 -20.51 -23.15 -18.75 -23.36 -45.23 -50.11 -46.23%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.